These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4817322)

  • 1. [Physiolical availability of medicinal agents in tablets and appraisal of their quality tests].
    Mikhaĭlova GS
    Farmatsiia; 1974; 23(1):80-3. PubMed ID: 4817322
    [No Abstract]   [Full Text] [Related]  

  • 2. A disintegration test for evaluation of drug availability from tablets and capsules.
    Sandell E; Eriksson K; Mellström G
    Acta Pharm Suec; 1970 Nov; 7(5):559-66. PubMed ID: 5275191
    [No Abstract]   [Full Text] [Related]  

  • 3. [Editorial: Biologic availability--aspects related to general practice].
    Schmidt R
    Schweiz Rundsch Med Prax; 1974 Jun; 63(23):697-8. PubMed ID: 4838647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G; Venier A
    Boll Chim Farm; 1973; 112(6):416-21. PubMed ID: 4767643
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measurement and quality control of dosage forms. XIX. Weibull's statistical distribution and its use in the study of mechanical strength of tablets].
    Zácek H; Muzík M
    Cesk Farm; 1981 Jun; 30(5):150-5. PubMed ID: 7296683
    [No Abstract]   [Full Text] [Related]  

  • 6. Some dissolution aspects of ferrous sulfate tablets.
    Blezek CE; Lach JL; Guillory JK
    Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139
    [No Abstract]   [Full Text] [Related]  

  • 8. [Release of drugs from tablets. I. Device estimating the release of drugs from tablets].
    Czarnecki W; Nerlo H
    Acta Pol Pharm; 1975; 32(2):227-32. PubMed ID: 1136833
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro comparison of the beaker, the rotating-basket and the column dissolution-rate methods.
    Bathe RV; Häfliger O; Langenbucher F; Schönleber D
    Pharm Acta Helv; 1975; 50(1-2):3-10. PubMed ID: 1114160
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trade names or approved names. Point II. Points of view. The clinical pharmacologist.
    Turner P
    Postgrad Med J; 1974 Feb; 50(580):93-5. PubMed ID: 4465784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the manufacturing and control of tablets. XII. Determination of drug release from single preparations in the in-vitro experiments].
    Lichnerová I; Chalabala M
    Cesk Farm; 1974 Mar; 23(2):88-93. PubMed ID: 4821802
    [No Abstract]   [Full Text] [Related]  

  • 13. Are all warfarin preparations Alike? A comprehensive overview of current data, emerging opinions, and perspectives.
    GiaQuinto NJ
    J Thromb Thrombolysis; 2000 Feb; 9(2):139-44. PubMed ID: 10613994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on tablets. XXII. Hardness of granulates, hardness of tablets and their mutual relationship].
    Rak J; Chalabala M; Slaný J
    Cesk Farm; 1976 Oct; 25(8):300-6. PubMed ID: 1009586
    [No Abstract]   [Full Text] [Related]  

  • 15. [Equivalency of drugs and the problem of biological availability].
    Hirtz J
    Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 17. The varying dissolution rates of phenylbutazone tablets.
    Thomas WH; McCarthy WB
    N Z Med J; 1970 Oct; 72(461):250-3. PubMed ID: 5275017
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
    Levy G; Barr WH
    Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factors influencing the bioavailability of drugs in the form of tablets].
    Cid E
    Pharm Acta Helv; 1974; 49(9-10):285-92. PubMed ID: 4462136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.